SCHEMBL30908423

SCHEMBL30908423

CC(=O)N(Cc1ccc2ccc(NC(=O)OC(C)(C)C)nc2c1)c1ccccc1SCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.41
HTR2C P28335 1/20 0.37
SLC6A4 P31645 1/20 0.37
NPY2R P49146 5/20 0.36
CCR2 P41597 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
IDO1 P14902 1/20 0.34
AKT1 P31749 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ADORA3 P0DMS8 3/20 0.33
TOP2A P11388 1/20 0.33
TOP2B Q02880 1/20 0.33
ACSS2 Q9NR19 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30908418 1.00 SCN9A (0.41) SCN9AHTR2CSLC6A4NPY2RCCR2
SCHEMBL30908572 0.91 SCN9A (0.35) SCN9AHTR2CSLC6A4NPY2RCCR2
SCHEMBL30908271 0.86 PTPN1 (0.36) SCN9AMEN1KMT2AAKT1ALDH1A1
SCHEMBL30908391 0.85 TOP2A (0.35) SCN9AMEN1KMT2AAKT1ALDH1A1
SCHEMBL30908503 0.83 NPC1 (0.35) SCN9ACCR2TOP2ATOP2B
SCHEMBL30908442 0.82 AURKA (0.37) SCN9AAKT1ALDH1A1TSHRTOP2A
SCHEMBL30908483 0.82 TSPO (0.39) SCN9ACCR2KMT2AAKT1ALDH1A1
SCHEMBL30908158 0.81 METAP1 (0.39) SCN9AAKT1TOP2ATOP2B
SCHEMBL30908405 0.81 HDAC1 (0.35) SCN9ATOP2ATOP2B
SCHEMBL30908222 0.79 METAP1 (0.38) SCN9AALDH1A1TSHRTOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024074611-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-04-11 WO disclosed